The policy of billing for patient portal messages changes patient expectations and can impact the patient-physician ...

An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.

The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.

Nurses were more likely than other health care workers to favor using AI-generated responses to patient portal messages.

Psilocybin-assisted psychotherapy “has the potential to be a comprehensive mental health treatment for patients with cancer,” ...

Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, a study suggests.

Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and ...

Short-course induction chemotherapy prior to chemoradiotherapy should be considered a standard of care, according to ...

The 5-year overall survival rate was 91.2% in patients diagnosed with hematologic malignancies during pregnancy and 90.3% in ...

Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product.

Nivolumab plus AVD “should be a strong candidate for primary treatment in adolescent and adult patients with stage III or IV Hodgkin’s lymphoma,” according to researchers.

Martin and colleagues’ latest study, published in June 2024 in JAMA Health Forum, finds that the Vot-ER project reaches a younger and more racially and ethnically diverse population, groups that are ...